AIM: We performed a retrospective study of 267 core needle aspiration biopsies in order to estimate the accuracy of CT-guided aspiration core needle biopsies for the diagnosis and subsequent treatment of @entity706 . MATERIALS AND METHODS: Between 1989 and 1999, 267 CT-guided core needle biopsies were performed in 241 @entity1 with either primary or recurrent @entity706 . @entity1 age ranged from 4--88 years. One hundred and sixty-six (62.2%) nodal and 101 (37.8%) extranodal aspiration biopsies were performed using either 18G or 20G Turner needles. Statistical method used was Chi-square analysis. RESULTS: An accurate histological diagnosis was made in 199 (82.5%) @entity1 , the remaining 42 (17.4%) @entity1 had non-diagnostic CT biopsies. Thirty-seven of them were diagnosed by a surgical biopsy, four by bone marrow biopsy and in one @entity1 by paracentesis. One hundred and seventy-nine @entity1 had @entity1893 ( @entity1893 ) and 62 had @entity978 ( @entity978 ); 23 (9.54%) @entity1 underwent repeated CT biopsy which was diagnostic in 17 (73.9%) and non-diagnostic in six (26%). CONCLUSION: CT-guided aspiration core biopsies were sufficient to establish a diagnosis in @entity1071 in 82.5% of cases. In the light of this experience we suggest that imaging-guided core needle biopsy be used as the first step in the work up of many @entity1 with @entity706 .

CT-guided biopsy with cutting-edge needle for the diagnosis of XXXX : experience of 267 biopsies.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity1071 :: ('MESH:D008232', 'Disease') :: ['lymphoproliferative disorders'] @entity706 :: ('MESH:D008223', 'Disease') :: ['lymphoma', 'malignant lymphoma'] @entity1893 :: ('MESH:D008228', 'Disease') :: ["non-Hodgkin's lymphoma", 'NHL'] @entity978 :: ('MESH:D006689', 'Disease') :: ['HD', "Hodgkin's disease"]
@entity706 :: (MESH:D008223,Disease) :: ['malignant lymphoma']
